Thymoma_with_immunodeficiency

Thymoma with immunodeficiency

Thymoma with immunodeficiency

Medical condition

Thymoma with immunodeficiency (also known as "Good syndrome") is a rare disorder that occurs in adults in whom hypogammaglobulinemia, deficient cell-mediated immunity, and thymoma (usually benign) may develop almost simultaneously.[1]: 82 [2] Most reported cases are in Europe, though it occurs globally.[3]

Quick Facts Other names ...

Dr. Robert Good was first to describe the association between thymoma and hypogammaglobulinemia in 1954.[4] Much remains to be understood about its pathogenesis.[5]

Signs and symptoms

Most patients present with an immunodeficient state and recurrent sinopulmonary infections in their 4th or 5th decade of life. The immunodeficiency may occur before or after the diagnosis of a thymoma.[4]

Immunodeficiency involves both deficient humoral and cellular immunity. Patients have low total serum antibodies. The thymoma may inhibit the thymus’s normal role in production of self-tolerant T lymphocytes. These T-lymphocytes then attack the B cell precursors in the marrow, preventing maturation and ultimately resulting in hypogammaglobulinemia.

It is characterized by increased susceptibility to bacterial, viral, and fungal infections.[6] Good Syndrome is associated with other autoimmune conditions including pure red cell aplasia[7] and myasthenia gravis.[4]

Pathogenesis

The cause of Good Syndrome is unknown. It is thought to be an autoimmune process affecting the bone marrow.[3]

Diagnosis

Definition

There are no formal diagnostic criteria.[5] Generally it can be defined as an adult-onset primary immunodeficiency associated with thymoma, hypogammaglobulinemia, diminished B and T cells, and inverted CD4/CD8+ ratio.[2] It has been suggested that Good Syndrome is a subset of common variable immunodeficiency (CVID).[3]

Treatment

The mainstay of treatment consists of thymectomy and immunoglobulin replacement with intravenous immunoglobulin. Immunodeficiency does not resolve after thymectomy. Immunosuppression is sometimes used.[2]

The Centers for Disease Control and Prevention recommend pneumococcal, meningococcal, and Hib vaccination in those with diminished humoral and cell-mediated immunity.

Some have advocated prophylaxis with trimethoprim-sulfamethoxazole if CD4 counts are lower than 200 cells/mm^3, similar to HIV/AIDS patients.

See also

References

  1. [1]
    James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: Clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0.
  2. [2]
    Miyakis, Spiros; Pefanis, Angelos; et al. (2006). "Thymoma with immunodeficiency (Good's syndrome): Review of the literature apropos three cases". Scandinavian Journal of Infectious Diseases. 38 (4): 314–320. doi:10.1080/00365540500372663. PMID 16718939. S2CID 44472631.
  3. [3]
    Kelesidis, Theodoros; Otto, Yang (2010). "Good's syndrome remains a mystery after 55 years: A systematic review of the scientific evidence". Clinical Immunology. 135 (3): 347–363. doi:10.1016/j.clim.2010.01.006. PMC 8071094. PMID 20149753.
  4. [4]
    Kelleher, P; Misbah, S A (2003). "What is Good's syndrome? Immunological abnormalities in patients with thymoma". Journal of Clinical Pathology. 56 (1): 12–16. doi:10.1136/jcp.56.1.12. PMC 1769851. PMID 12499426.
  5. [5]
    Jansen, Anne; van Deuren, Marcel; et al. (2016). "Prognosis of Good syndrome: mortality and morbidity of thymoma associated immunodeficiency in perspective". Clinical Immunology. 171: 12–17. doi:10.1016/j.clim.2016.07.025. hdl:2066/171270. PMID 27497628.
  6. [6]
    Grammatikos, A., Bright, P., Pearson, J. et al. Chronic Enteroviral Meningoencephalitis in a Patient with Good’s Syndrome Treated with Pocapavir. J Clin Immunol (2022). https://doi.org/10.1007/s10875-022-01321-6
  7. [7]
    Hirokawa, Makoto; Sawada, Ken-ichi; et al. (January 2008). "Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group". Haematologica. 93 (1): 27–33. doi:10.3324/haematol.11655. PMID 18166782.
Share this article:

This article uses material from the Wikipedia article Thymoma_with_immunodeficiency, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.